Industry
Cortendo AB
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
50%
3 of 6 completed trials have results
Key Signals
3 with results
Enrollment Performance
Analytics
Phase 3
3(50.0%)
Phase 1
3(50.0%)
6Total
Phase 3(3)
Phase 1(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT03621280Phase 3Completed
Open-label Treatment in Cushing's Syndrome
Role: lead
NCT03277690Phase 3Completed
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
Role: lead
NCT01838551Phase 3Completed
Treatment for Endogenous Cushing's Syndrome
Role: lead
NCT04212000Phase 1Completed
Bioavailability of Levoketoconazole and Ketoconazole Tablets
Role: lead
NCT03880825Phase 1Completed
Drug Interaction Study of Levoketoconazole and Metformin
Role: lead
NCT03768388Phase 1Completed
Levoketoconazole Food Effect Study in Healthy Subjects
Role: lead
All 6 trials loaded